Related Experiment Video
Updated: Aug 17, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A
C X Gong1, I Grundke-Iqbal, K Iqbal
1New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.
Abstract:
Microtubule-associated protein tau is abnormally hyperphosphorylated in the brain of patients with Alzheimer's disease, and is the major protein subunit of paired helical filaments. There is also a significant pool of non-paired helical filament abnormally phosphorylated tau in Alzheimer's disease brain. In the present study, the site-specific dephosphorylation of this Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A was studied and compared with that by protein phosphatase-2B. The dephosphorylation was detected by its interaction with several phosphorylation-dependent antibodies to various abnormal phosphorylation sites. Protein phosphatase-2A was able to dephosphorylate the abnormally phosphorylated tau at Ser-46, Ser-199, Ser-202, Ser-396 and Ser-404, but not at Ser-235 (the amino acids are numbered according to the largest isoform of human tau, tau441). Two major types of protein phosphatase-2A, protein phosphatase-2A1 and -2A2, dephosphorylated the abnormally phosphorylated tau at approximately the same rate. After the abnormally phosphorylated tau was dephosphorylated by protein phosphatase-2A, its relative mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis increased. The dephosphorylation of the abnormal tau by protein phosphatase-2A1 and -2A2 was markedly stimulated by Mn2+. These results suggest that tau dephosphorylation is catalysed by protein phosphatase-2A in addition to protein phosphatase-2B. A deficiency of either protein phosphatase-2A or -2B, or both, may be involved in abnormal phosphorylation of tau in Alzheimer's disease.
Insights
Protein phosphatase-2A dephosphorylates abnormal tau protein at specific sites, suggesting its role in Alzheimer's disease pathogenesis alongside protein phosphatase-2B. A deficiency in these phosphatases may contribute to tau hyperphosphorylation.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Abnormal hyperphosphorylation of tau protein is a hallmark of Alzheimer's disease (AD).
- Hyperphosphorylated tau forms paired helical filaments and other aggregates in AD brains.
- A significant pool of non-paired helical filament abnormally phosphorylated tau also exists in AD.
Purpose of the Study:
- To investigate the site-specific dephosphorylation of abnormally phosphorylated tau by protein phosphatase-2A (PP2A).
- To compare the activity of PP2A with protein phosphatase-2B (PP2B) in dephosphorylating tau.
- To explore the potential involvement of PP2A and PP2B deficiencies in AD-related tau pathology.
Main Methods:
- Site-specific dephosphorylation of AD-associated hyperphosphorylated tau by PP2A and PP2B.
- Detection of dephosphorylation using phosphorylation-dependent antibodies targeting specific tau sites (Ser-46, Ser-199, Ser-202, Ser-396, Ser-404, Ser-235).
- Analysis of changes in tau mobility on SDS-PAGE post-dephosphorylation and the effect of Mn2+ stimulation.
Main Results:
- PP2A effectively dephosphorylated tau at Ser-46, Ser-199, Ser-202, Ser-396, and Ser-404, but not Ser-235.
- Both PP2A1 and PP2A2 isoforms dephosphorylated tau at similar rates.
- Dephosphorylation by PP2A increased tau's relative mobility on SDS-PAGE and was stimulated by Mn2+.
Conclusions:
- Tau dephosphorylation is catalyzed by PP2A, in addition to PP2B.
- PP2A plays a significant role in regulating tau phosphorylation.
- Deficiencies in PP2A or PP2B may contribute to the abnormal tau phosphorylation observed in Alzheimer's disease.
More Related Videos
12:47Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction